DE69329899T2 - Behandlung von tropikalischer spastischer Paresis mit Peptide T - Google Patents
Behandlung von tropikalischer spastischer Paresis mit Peptide TInfo
- Publication number
- DE69329899T2 DE69329899T2 DE69329899T DE69329899T DE69329899T2 DE 69329899 T2 DE69329899 T2 DE 69329899T2 DE 69329899 T DE69329899 T DE 69329899T DE 69329899 T DE69329899 T DE 69329899T DE 69329899 T2 DE69329899 T2 DE 69329899T2
- Authority
- DE
- Germany
- Prior art keywords
- thr
- amino
- ser
- residue
- terminal residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108010071384 Peptide T Proteins 0.000 title 1
- 206010044696 Tropical spastic paresis Diseases 0.000 title 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 125000000729 N-terminal amino-acid group Chemical group 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 102000004217 thyroid hormone receptors Human genes 0.000 abstract 2
- 108090000721 thyroid hormone receptors Proteins 0.000 abstract 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000002981 blocking agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/898,691 US6242564B1 (en) | 1986-06-03 | 1992-06-15 | Treatment of tropical spastic paresis with peptide T |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69329899D1 DE69329899D1 (de) | 2001-03-08 |
| DE69329899T2 true DE69329899T2 (de) | 2001-05-23 |
Family
ID=25409893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69329899T Expired - Fee Related DE69329899T2 (de) | 1992-06-15 | 1993-05-20 | Behandlung von tropikalischer spastischer Paresis mit Peptide T |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6242564B1 (de) |
| EP (1) | EP0579363B1 (de) |
| JP (1) | JPH06247874A (de) |
| AT (1) | ATE198987T1 (de) |
| AU (1) | AU671989B2 (de) |
| DE (1) | DE69329899T2 (de) |
| DK (1) | DK0579363T3 (de) |
| IL (1) | IL105822A (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5739109A (en) * | 1988-12-16 | 1998-04-14 | Advanced Immunit Inc. | Method of treating neuroinflammatory degenerative diseases |
| US5567682A (en) * | 1988-12-16 | 1996-10-22 | Advanced Peptides And Biotechnology Sciences | Method of treating Alzheimer's disease |
| DE69433817T2 (de) * | 1993-09-24 | 2005-07-14 | Advanced Immuni T, Inc. | Lineare und cyklische peptide zur behandlung oder vorbeugung der crohn'schen krankheit und/oder der ulzerativen kolitis |
| EP0871466B1 (de) * | 1993-09-24 | 2004-05-06 | Advanced Immuni T, Inc. | Lineare und cyklische peptide zur behandlung oder verhinderung von ekzem und dermatitis |
| AUPM365794A0 (en) * | 1994-02-02 | 1994-02-24 | Minister for Agriculture & Rural Affairs for the State of NSW, The | Biocontrol of take-all using phialophora sp. (lobed hyphopodia) |
| WO1997031628A1 (en) * | 1996-02-28 | 1997-09-04 | Innapharma, Inc. | Peptidomimetics for the treatment of hiv infection |
| EP1242109A4 (de) * | 1999-11-09 | 2004-06-02 | Advanced Immunit Inc | Verfahren zur behandlung von viuruserkrankungen und anderen störungen durch veränderung der "immediate gene expression" durch verabreichung von peptid t |
| MX2007016573A (es) | 2005-06-23 | 2008-10-17 | Rapid Pharmaceuticals Inc | Vacunas y peptidos terapeuticos. |
| CN101088557A (zh) | 2006-06-12 | 2007-12-19 | 天津市扶素生物技术有限公司 | 用于预防或治疗hiv感染的药用组合物及其应用 |
| US10501494B2 (en) | 2013-04-26 | 2019-12-10 | Creative Bio-Peptides | Uses of peptides to treat brain injury and disease |
| US10624944B2 (en) * | 2017-06-19 | 2020-04-21 | Creative Bio-Peptides Inc. | Anti-inflammatory peptides for treating non-alcoholic steatohepatitis (NASH) |
| US11510961B2 (en) | 2019-12-19 | 2022-11-29 | Creative Bio-Peptides, Inc. | Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4689398A (en) * | 1984-06-20 | 1987-08-25 | Ortho Diagnostic Systems Inc. | HTLV test using synthetic peptides |
| AU7544987A (en) * | 1986-06-03 | 1988-01-11 | Pert, C.B. | Small peptides which inhibit binding to t-4 receptors |
| EP0249394B1 (de) * | 1986-06-03 | 1993-10-27 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Kleine Peptide, die die Bindung an T-4-Rezeptoren inhibieren und als Immunogene wirken |
| US5063206A (en) * | 1988-12-16 | 1991-11-05 | The United States Of Americas As Represented By The Department Of Health And Human Services | Compositions having use as treatment of neuropsychiatric deficits |
| WO1989012067A1 (en) * | 1988-05-27 | 1989-12-14 | The United States Of America, As Represented By Th | Compositions having use as treatment of psoriasis and neuropsychiatric deficits |
| US5689398A (en) * | 1996-01-03 | 1997-11-18 | Allen-Bradley Company, Inc. | Redundant control relay circuits |
-
1992
- 1992-06-15 US US07/898,691 patent/US6242564B1/en not_active Expired - Fee Related
-
1993
- 1993-05-20 AT AT93303919T patent/ATE198987T1/de not_active IP Right Cessation
- 1993-05-20 DE DE69329899T patent/DE69329899T2/de not_active Expired - Fee Related
- 1993-05-20 DK DK93303919T patent/DK0579363T3/da active
- 1993-05-20 EP EP93303919A patent/EP0579363B1/de not_active Expired - Lifetime
- 1993-05-21 AU AU38719/93A patent/AU671989B2/en not_active Ceased
- 1993-05-28 IL IL10582293A patent/IL105822A/en not_active IP Right Cessation
- 1993-06-11 JP JP5166067A patent/JPH06247874A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATE198987T1 (de) | 2001-02-15 |
| US6242564B1 (en) | 2001-06-05 |
| IL105822A (en) | 1999-11-30 |
| IL105822A0 (en) | 1993-09-22 |
| EP0579363B1 (de) | 2001-01-31 |
| EP0579363A1 (de) | 1994-01-19 |
| AU671989B2 (en) | 1996-09-19 |
| AU3871993A (en) | 1993-12-16 |
| DK0579363T3 (da) | 2001-02-19 |
| DE69329899D1 (de) | 2001-03-08 |
| JPH06247874A (ja) | 1994-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69032600D1 (de) | Rekombinanter abkömmling des menschlichen faktors iii | |
| NL300013I1 (nl) | Nieuwe protein met TNF-remmende werking en hun ber | |
| DE69329899D1 (de) | Behandlung von tropikalischer spastischer Paresis mit Peptide T | |
| ES2075040T3 (es) | 2',3'-dideoxi-2',2'-difluoronucleosidos. | |
| ATE154363T1 (de) | Synthetische polypeptide als inhibitoren von hiv- 1 | |
| DE69731097D1 (de) | Conotoxin peptid pviia | |
| RU96104348A (ru) | Профилактика спида | |
| CA2334941A1 (en) | Tnf-derived peptides for use in treating oedema | |
| DK0573538T3 (da) | Peptider til behandling | |
| ATE96450T1 (de) | Kleine peptide, die die bindung an t-4-rezeptoren inhibieren und als immunogene wirken. | |
| ATE42308T1 (de) | Pharmakologisch aktive peptide. | |
| DE3751398D1 (de) | Substrat-Peptide. | |
| DK0426314T3 (da) | HIV-relaterede peptider | |
| DE59710091D1 (de) | Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie | |
| ATE92078T1 (de) | Pharmakologisch aktive peptide. | |
| WO1994004565A3 (en) | Ipnv vaccine | |
| WO1997025343A3 (en) | Antithrombotic agents and methods of use | |
| ATE46173T1 (de) | Pharmakologisch aktive peptide. | |
| ES2061497T3 (es) | Peptidos cortos que inhiben la fijacion a receptores t-4 y actuan como inmunogenos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8381 | Inventor (new situation) |
Free format text: PERT, CANDACE B., POTOMAC, MARYLAND 20854, US RUFF, MICHAEL R., POTOMAC, MARYLAND 20854, US |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: ADVANCED IMMUNI T, INC.(N.D.GES.D. STAATES DELAWAR |
|
| 8328 | Change in the person/name/address of the agent |
Representative=s name: PUSCHMANN & BORCHERT, 82041 OBERHACHING |
|
| 8339 | Ceased/non-payment of the annual fee |